Immuto Scientific, a trailblazing company co-founded in 2018 by CEO Faraz A. Choudhury, Ph.D., and CTO Daniel Benjamin, Ph.D., both…
Read More
How Immuto Scientific pairs AI and mass spec for a step change in protein structure throughput
Redefining Vitamin B12 Sufficiency for Brain Health in Aging Populations
A landmark study led by researchers at the University of California, San Francisco (UCSF) has sparked a critical debate within…
Read More
Washington University Researchers Develop High Efficiency Platinum Free Catalyst for Green Hydrogen Production
In a significant advancement for the global transition toward sustainable energy, researchers at the McKelvey School of Engineering at Washington…
Read More
ASCO 2026: Lung Cancer Landscape Ignites with Promising Bispecifics, Targeted Therapies, and Extended Survival Data
The annual American Society of Clinical Oncology (ASCO) congress, a cornerstone event for the global oncology community, convened in Chicago,…
Read More
The Alarming Rise of AI Chatbots in Youth Mental Healthcare: A Silent Epidemic
A growing number of adolescents and young adults are turning to artificial intelligence chatbots for mental health support, a trend…
Read More
Mastering Synthetic IoT Data Generation for Advanced Analytics and Machine Learning
The burgeoning Internet of Things (IoT) ecosystem, characterized by an exponential growth in connected devices and sensors, presents a paradoxical…
Read More
A Century-Old Understanding of Inheritance is Being Redefined by New Discoveries in Epigenetics
For over a century, the foundational principles of biology have been anchored in Gregor Mendel’s meticulously documented laws of inheritance,…
Read More
Genomic Breakthrough Reveals the Explosive Pre-Clinical Growth and Evolutionary Timeline of Chronic Myeloid Leukemia
A landmark study led by the Wellcome Sanger Institute has fundamentally altered the scientific understanding of how chronic myeloid leukemia…
Read More
Singaporean Scientists Unveil Revolutionary Spinach-Derived Photosynthetic Treatment for Chronic Dry Eye Disease
The landscape of ophthalmological treatments is on the cusp of a profound transformation, spearheaded by groundbreaking research from the National…
Read More
Lilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?
Eli Lilly and Company is embarking on a significant acquisition spree, exemplified by its recent agreement to acquire Kelonia Therapeutics…
Read More